Characterisation of new in vitro models and identification of potentially active drugs in angiosarcoma

Biomed Pharmacother. 2024 Apr:173:116397. doi: 10.1016/j.biopha.2024.116397. Epub 2024 Mar 12.

Abstract

Angiosarcoma is a rare soft tissue sarcoma originating from endothelial cells. Given that current treatments for advanced disease have shown limited efficacy, alternative therapies need to be identified. In rare diseases, patient-derived cell models are crucial for screening anti-tumour activity. In this study, cell line models were characterised in 2D and 3D cultures. The cell lines' growth, migration and invasion capabilities were explored, confirming them as useful tools for preclinical angiosarcoma studies. By screening a drug library, we identified potentially effective compounds: 8-amino adenosine impacted cell growth and inhibited migration and invasion at considerably low concentrations as a single agent. No synergistic effect was detected when combining with paclitaxel, gemcitabine or doxorubicin. These results suggest that this compound could be a potentially useful drug in the treatment of AGS.

Keywords: 8AA; Angiosarcoma; Cellular model; Treatment.

MeSH terms

  • Doxorubicin / pharmacology
  • Doxorubicin / therapeutic use
  • Endothelial Cells / pathology
  • Hemangiosarcoma* / drug therapy
  • Humans
  • Paclitaxel / pharmacology
  • Paclitaxel / therapeutic use
  • Sarcoma* / drug therapy

Substances

  • Doxorubicin
  • Paclitaxel